| SKIP001142 |
| SKIP ID |
SKIP001142 |
| Organism(En) |
- |
| Organism(Ja) |
- |
| Cell Type(En) |
- |
| Cell Type(Ja) |
- |
| Cell Tissue(En) |
CD34+ cells |
| Cell Tissue(Ja) |
CD34+ cells |
| Cell Origin |
Normal |
| Cell Name 1(En) |
ATCC-BXS0114 |
| Cell Name 1(Ja) |
ATCC-BXS0114 |
| Cell Name 2(En) |
- |
| Cell Name 2(Ja) |
- |
| Disease Name 1(Ja) |
- |
| ICD Code 1 |
- |
| Disease Name 1(En) |
- |
| OMIM1 |
- |
| Disease Name 2(Ja) |
- |
| ICD Code 2 |
- |
| Disease Name 2(En) |
- |
| OMIM 2 |
- |
| Disease Name 3(Ja) |
- |
| ICD Code 3 |
- |
| Disease Name 3(En) |
- |
| OMIM 3 |
- |
| Age |
31 |
| Age Range |
30-39 |
| Sex |
Female |
| Race(En) |
- |
| Race(Ja) |
- |
| Genetic Diagnosis |
-- |
| Not Detected |
No |
| Description(En) |
ATCC-BXS0114 Human Induced Pluripotent Stem Cells (iPSCs) were derived from bone marrow CD34+ cells obtained from a healthy African American Female donor.
|
| Description(Ja) |
健常人の骨髄由来iPS細胞。 |
| Cell Morphology |
human ES-like |
| Grade |
Research Grade |
| Vector |
Sendai virus |
| Transgene |
Oct4, Sox2, Klf4, c-Myc |
| Adhesiveness |
- |
| Feeder |
No |
| Feeder Cell |
- |
| Medium |
Pluripotent Stem Cell SFM XF/FF |
| Genome Editing |
- |
| CO2 |
- |
| Mycoplasma |
- |
| Detection of Contaminants Mycoplasma |
- |
| Pluripotent Markers |
Yes |
| Pluripotent Markers Assay |
- |
| in vitro Differentiation |
- |
| in vitro Differentiation Assay |
- |
| in vivo Differentiation |
- |
| in vivo Differentiation Assay |
- |
| Other 1 Assay |
- |
| Other 1 Assay Method |
- |
| Other 2 Assay |
- |
| Other 2 Assay Method |
- |
| Other 3 Assay |
- |
| Other 3 Assay Method |
- |
| Karyotype |
Yes |
| Karyotype Assay |
- |
| Remaining Vector Detection |
- |
| Remaining Vector Detection Assay |
- |
| STR |
- |
| HLA |
- |
| Stem Cell Transcriptome analysis |
- |
| Stem Cell Transcriptome analysis Assay |
- |
| Author Name(En) |
Summit Pharmaceuticals Intl. Corp. |
| Author Name(Ja) |
住商ファーマインターナショナル株式会社 |
| Author Organization(En) |
Summit Pharmaceuticals Intl. Corp. |
| Author Organization(Ja) |
住商ファーマインターナショナル株式会社 |
| Author Contact Email |
atcc[at]summitpharma[dot]co[dot]jp |
| PI Organization(En) |
American Type Culture Collection (ATCC) |
| PI Organization(Ja) |
American Type Culture Collection (ATCC) |
| PI Name(En) |
American Type Culture Collection (ATCC) |
| PI Name(Ja) |
American Type Culture Collection (ATCC) |
| PI Contact Email |
Tech[at]atcc[dot]org |
| Availability |
Available |
| Provider Organization(En) |
Summit Pharmaceuticals Intl. Corp. |
| Provider Organization(Ja) |
住商ファーマインターナショナル株式会社 |
| Provider Email |
atcc[at]summitpharma[dot]co[dot]jp |
| Provider URL |
http://www.summitpharma.co.jp |
| Ethical Statement(En) |
- |
| Ethical Statement(Ja) |
- |
| Terms of Use(En) |
- |
| Terms of Use(Ja) |
- |
| PubMed ID |
- |
| DOI |
- |
| Title |
- |
| Authors |
- |
| Journal |
- |
| Year |
- |
| Volume |
- |
| Issue |
- |
| Pages |
- |
| URL |
- |
| Free input |
- |
| Note |
- |